Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab continuation in psoriatic arthritis
NCT00195689Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Aug 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in psoriatic arthritis (PsA), sponsored by Abbott Laboratories. Primary endpoint: Safety parameters. Started Aug 2003; status: completed.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT00195689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195689.